Where There's Smoke, There's Fire: Toxic Exposure and Inflammation

Between COVID-19 spikes and the historical wildfires that have ravaged many areas, we cannot ignore the toxic exposure that has been added to our patients overall burden during the past months.

At any given point in time we are all at a “tipping point”, where epigenetics can overwhelm our genetic tolerance when it comes to detoxification capacity and inflammatory pathways. Stanford University’s Mary Prunicki, the center’s Director of Air Pollution and Health Research, recently summarized why we need to be concerned about wildfire smoke, COVID, immune dysfunction, and inflammation:

“Given that 80% of wildfire smoke is PM2.5 [fine particulate matter], we expect acute immune dysregulation....Areas of elevated air pollution are associated with increased COVID-19 rates, exposure probably renders the body less able to fight off viral infections, such as COVID-19.” ¹

In this webinar, we will share timely information to help you and your patients mitigate the impacts of toxic exposure, which is especially critical right now. Topics include:

• Vitally important statistics about benzene, toluene, phthalates, parabens and other persistent organic pollutants (POPs)
• Clinical pearls on specific physiological effects within the human body
• How to test your patients for environmental pollutants
• Treatment considerations, with immediately actionable information for clinical providers.